BE743906A - - Google Patents
Info
- Publication number
- BE743906A BE743906A BE743906DA BE743906A BE 743906 A BE743906 A BE 743906A BE 743906D A BE743906D A BE 743906DA BE 743906 A BE743906 A BE 743906A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR182572A FR8491M (US20070244113A1-20071018-C00087.png) | 1968-12-31 | 1968-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE743906A true BE743906A (US20070244113A1-20071018-C00087.png) | 1970-05-28 |
Family
ID=8659686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE743906D BE743906A (US20070244113A1-20071018-C00087.png) | 1968-12-31 | 1969-12-30 |
Country Status (10)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3933829A (en) * | 1974-08-22 | 1976-01-20 | John Wyeth & Brother Limited | 4-Aminoquinoline derivatives |
| JPS5618674Y2 (US20070244113A1-20071018-C00087.png) * | 1974-12-28 | 1981-05-01 | ||
| FR2581382B1 (fr) * | 1985-05-06 | 1987-06-26 | Sanofi Sa | Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes |
| US8309562B2 (en) * | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| AU2004253967B2 (en) | 2003-07-03 | 2010-02-18 | Cytovia, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| US8258145B2 (en) * | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
-
1968
- 1968-12-31 FR FR182572A patent/FR8491M/fr not_active Expired
-
1969
- 1969-12-23 CH CH1909769A patent/CH513169A/fr not_active IP Right Cessation
- 1969-12-23 CH CH1199269A patent/CH517095A/fr not_active IP Right Cessation
- 1969-12-23 CH CH1909869A patent/CH511230A/fr not_active IP Right Cessation
- 1969-12-30 ES ES375026A patent/ES375026A1/es not_active Expired
- 1969-12-30 NL NL6919624A patent/NL6919624A/xx unknown
- 1969-12-30 NL NL6919623A patent/NL6919623A/xx unknown
- 1969-12-30 ES ES375025A patent/ES375025A1/es not_active Expired
- 1969-12-30 NL NL6919625A patent/NL6919625A/xx unknown
- 1969-12-30 BE BE743906D patent/BE743906A/xx unknown
- 1969-12-30 ES ES375024A patent/ES375024A1/es not_active Expired
- 1969-12-31 JP JP44105572A patent/JPS4823437B1/ja active Pending
- 1969-12-31 CA CA071239A patent/CA935159A/en not_active Expired
- 1969-12-31 DE DE19691965638 patent/DE1965638A1/de active Pending
- 1969-12-31 JP JP44105574A patent/JPS4815951B1/ja active Pending
- 1969-12-31 GB GB1301490D patent/GB1301490A/en not_active Expired
-
1972
- 1972-06-07 US US00260527A patent/US3769410A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CH517095A (fr) | 1971-12-31 |
| DE1965638A1 (de) | 1970-09-03 |
| CH511230A (fr) | 1971-08-15 |
| NL6919625A (US20070244113A1-20071018-C00087.png) | 1970-07-02 |
| CH513169A (fr) | 1971-09-30 |
| JPS4823437B1 (US20070244113A1-20071018-C00087.png) | 1973-07-13 |
| ES375024A1 (es) | 1972-03-01 |
| CA935159A (en) | 1973-10-09 |
| GB1301490A (US20070244113A1-20071018-C00087.png) | 1972-12-29 |
| ES375025A1 (es) | 1972-03-01 |
| JPS4815951B1 (US20070244113A1-20071018-C00087.png) | 1973-05-18 |
| FR8491M (US20070244113A1-20071018-C00087.png) | 1973-07-27 |
| NL6919623A (US20070244113A1-20071018-C00087.png) | 1970-07-02 |
| US3769410A (en) | 1973-10-30 |
| ES375026A1 (es) | 1972-03-01 |
| NL6919624A (US20070244113A1-20071018-C00087.png) | 1970-07-02 |
